We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 40

Securing IP in stem cells

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • April 12 2013

Stem cells are at the centre of research into regenerative medicine. They have the ability to continuously produce newly differentiated cells and

Mobile app developers must safeguard privacy: new guidelines introduced in Canada and the U.S.

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • December 6 2012

This October, the Federal, Alberta, and British Columbia privacy commissioners released guidelines to help mobile application developers comply with Canada’s federal and provincial privacy laws

It’s not easy being green: FTC issues new Green Guides in the U.S.

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • December 4 2012

In October 2012, the U.S. Federal Trade Commission released new Green Guides

The Louboutin decision a step in the right direction for colour marks

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • October 2 2012

The Second Circuit of Appeal of the United States recently released a decision of importance to brand owners and of particular significance to the fashion industry

New strategies for green tech patents bloom in Canada and the U.S.

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • July 20 2012

The United States Patent and Trademark Office (USPTO) Green Technology Pilot Program has closed and is no longer accepting additional applications

Common sense and obviousness: supporting evidence is required

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • June 12 2012

Whether enforcing a patent or prosecuting a patent application, obviousness is often the key issue

Dealing with inventors who refuse to cooperate or disappear

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • June 12 2012

When employees have a falling out with their employers, concerns can arise if the employee is named as an inventor in a pending or soon-to-be-filed patent application and they are either unwilling to sign documents or unavailable

Determining patentable subject matter in the United States and Canada

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • April 10 2012

As reported in our March 21, 2012, Spring Alert, the United States Supreme Court recently held in Prometheus v. Mayo that certain personalized medicine claims were directed to laws of nature and were thus unpatentable despite containing both an administering step and a determining step

Biosimilar battlegrounds - what is new in biosimilars and where?

  • Bereskin & Parr LLP
  • -
  • Canada, European Union, USA
  • -
  • February 17 2012

Biosimilars are second entry biologic drugs

AIA, eh? a Canadian perspective

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • December 15 2011

Unless you began your winter hibernation early, you will have heard that, on September 16, 2011, the Leahy-Smith America Invents Act or (AIA), was signed into force by President Obama representing the first comprehensive overhaul to U.S. patent law in 60 years

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy